The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 10, 2015
Filed:
Jul. 10, 2009
Applicants:
Dennis Rylatt, Wheelers Hill, AU;
Alastair Hodges, Blackburn South, AU;
Inventors:
Dennis Rylatt, Wheelers Hill, AU;
Alastair Hodges, Blackburn South, AU;
Assignee:
Universal Biosensors Pty Ltd, Rowville, AU;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/543 (2006.01); G01N 33/537 (2006.01); G01N 33/538 (2006.01); G01N 33/539 (2006.01); G01N 33/541 (2006.01); G01N 33/558 (2006.01); G01N 33/58 (2006.01); G01N 33/66 (2006.01); C12Q 1/00 (2006.01); C12Q 1/26 (2006.01); C12Q 1/32 (2006.01); B01L 3/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/54366 (2013.01); G01N 33/53 (2013.01); G01N 33/5302 (2013.01); G01N 33/5306 (2013.01); G01N 33/537 (2013.01); G01N 33/538 (2013.01); G01N 33/539 (2013.01); G01N 33/541 (2013.01); G01N 33/558 (2013.01); G01N 33/581 (2013.01); G01N 33/66 (2013.01); C12Q 1/001 (2013.01); C12Q 1/004 (2013.01); C12Q 1/005 (2013.01); C12Q 1/006 (2013.01); C12Q 1/26 (2013.01); C12Q 1/32 (2013.01); B01L 3/5027 (2013.01); G01N 33/54393 (2013.01); B01L 2200/0621 (2013.01); B01L 2200/10 (2013.01); B01L 2300/0645 (2013.01); B01L 2300/0825 (2013.01); B01L 2300/087 (2013.01); B01L 2400/0406 (2013.01); B01L 2400/0694 (2013.01);
Abstract
Disclosed herein are devices for detecting the presence of a target analyte in a fluid sample. The biosensor device can comprise at least a reaction chamber and a detection chamber. The device can comprise a amplifying mechanism such that one target analyte molecule present in the fluid sample can lead to generation/activation of multiple detection agent molecules, and therefore, an amplified signal. Also disclosed are the methods of manufacturing and using such a biosensor device.